Opportunities and obstacles in developing a vaccine for Entamoeba histolytica (Q30309840)

16 June 2017

1 reference

title

Opportunities and obstacles in developing a vaccine for Entamoeba histolytica (English)

1 reference

16 June 2017

main subject

Entamoeba histolytica

1 reference

2

William A Petri

1 reference

16 June 2017

Vanessa C Miller-Sims

series ordinal

1

object named as

Vanessa C Miller-Sims

1 reference

16 June 2017

publication date

1 October 2002

1 reference

Current Opinion in Immunology

16 June 2017

published in

1 reference

16 June 2017

volume

14

1 reference

16 June 2017

issue

5

1 reference

16 June 2017

page(s)

549-552

1 reference

Prospects for the use of new vaccines in developing countries: cost is not the only impediment.

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900372-2

7 January 2021

A redescription of Entamoeba histolytica Schaudinn, 1903 (Emended Walker, 1911) separating it from Entamoeba dispar Brumpt, 1925.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900372-2

7 January 2021

Entamoeba histolytica and Entamoeba dispar infection in children in Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900372-2

7 January 2021

The bittersweet interface of parasite and host: lectin-carbohydrate interactions during human invasion by the parasite Entamoeba histolytica

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900372-2

7 January 2021

Pore-forming peptide of pathogenic Entamoeba histolytica

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900372-2

7 January 2021

Caspase 3-dependent killing of host cells by the parasite Entamoeba histolytica

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900372-2

7 January 2021

Isolation and characterization of phagocytosis- and virulence-deficient mutants of Entamoeba histolytica

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900372-2

7 January 2021

Infection and immunity mediated by the carbohydrate recognition domain of the Entamoeba histolytica Gal/GalNAc lectin

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900372-2

7 January 2021

Antisense inhibition of expression of the light subunit (35 kDa) of the Gal/GalNac lectin complex inhibits Entamoeba histolytica virulence

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900372-2

7 January 2021

Protection in a gerbil model of amebiasis by oral immunization with Salmonella expressing the galactose/N-acetyl D-galactosamine inhibitable lectin of Entamoeba histolytica

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900372-2

7 January 2021

Considerations for combination vaccine development and use in the developing world

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900372-2

7 January 2021

Developing Country Vaccine Manufacturers Network (DCVMN), 26-27 April 2001, Bandung, Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2802%2900372-2

7 January 2021

10.1016/S0952-7915(02)00372-2

Identifiers

DOI

1 reference

16 June 2017

1 reference